Ann M. Hanly - Mar 30, 2023 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
Chief Technology Officer
Signature
/s/ Vanina de Verneuil, Attorney-in-fact
Stock symbol
VIR
Transactions as of
Mar 30, 2023
Transactions value $
-$59,817
Form type
4
Date filed
3/31/2023, 02:40 PM
Previous filing
Feb 24, 2023
Next filing
Feb 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Sale -$59.8K -2.63K -2.24% $22.77 115K Mar 30, 2023 Direct F1
holding VIR Common Stock 11.5 Mar 30, 2023 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
F2 The shares are beneficially owned by the reporting person's spouse, for the benefit of a minor child.